;PMID: 8858760
;source_file_2856.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..125] = [t:48..125]
;2)section:[e:129..157] = [t:129..157]
;3)section:[e:161..278] = [t:161..278]
;4)sentence:[e:282..501] = [t:282..501]
;5)sentence:[e:502..663] = [t:502..663]
;6)sentence:[e:664..818] = [t:664..818]
;7)sentence:[e:819..908] = [t:819..908]
;8)sentence:[e:909..1020] = [t:909..1020]
;9)sentence:[e:1021..1147] = [t:1021..1147]
;10)sentence:[e:1148..1253] = [t:1148..1253]
;11)section:[e:1257..1275] = [t:1257..1275]
;12)section:[e:1281..1287] = [t:1281..1287]
;13)section:[e:1293..1309] = [t:1293..1309]
;14)section:[e:1313..1357] = [t:1313..1357]

;section 0 Span:0..42
;Semin Pediatr Surg.  1996 Aug;5(3):149-54.
(SEC
  (FRAG (NNP:[0..5] Semin) (NNP:[6..13] Pediatr) (NNP:[14..18] Surg)
        (.:[18..19] .) (CD:[21..25] 1996) (IN:[26..30] Aug;) (CD:[30..31] 5)
        (NN:[31..32] -LRB-) (NN:[32..33] 3) (-RRB-:[33..34] -RRB-)
        (::[34..35] :) (CD:[35..39] 149-) (CD:[39..41] 54) (.:[41..42] .)))

;sentence 1 Span:48..125
;cDNA subtraction hybridization: a review and an application to
;neuroblastoma.
;[111..124]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (NN:[48..52] cDNA) (NN:[53..64] subtraction) (NN:[65..78] hybridization))
    (::[78..79] :)
    (NP
      (NP (DT:[80..81] a) (NN:[82..88] review))
      (CC:[89..92] and)
      (NP
        (NP (DT:[93..95] an) (NN:[96..107] application))
        (PP (TO:[108..110] to)
          (NP (NN:[111..124] neuroblastoma)))))
    (.:[124..125] .)))

;section 2 Span:129..157
;Swendeman SL, La Quaglia MP.
(SEC
  (FRAG (NNP:[129..138] Swendeman) (NNP:[139..141] SL) (,:[141..142] ,)
        (NNP:[143..145] La) (NNP:[146..153] Quaglia) (NN:[154..156] MP)
        (.:[156..157] .)))

;section 3 Span:161..278
;Department of Surgery (Pediatric Surgical Service), Memorial Sloan-Kettering 
;Cancer Center, New York, NY 10021, USA.
(SEC
  (FRAG (NNP:[161..171] Department) (IN:[172..174] of) (NNP:[175..182] Surgery)
        (-LRB-:[183..184] -LRB-) (NNP:[184..193] Pediatric)
        (NNP:[194..202] Surgical) (NNP:[203..210] Service)
        (-RRB-:[210..211] -RRB-) (,:[211..212] ,) (JJ:[213..221] Memorial)
        (NNP:[222..227] Sloan) (HYPH:[227..228] -) (NNP:[228..237] Kettering)
        (NNP:[239..245] Cancer) (NNP:[246..252] Center) (,:[252..253] ,)
        (NNP:[254..257] New) (NNP:[258..262] York) (,:[262..263] ,)
        (NNP:[264..266] NY) (CD:[267..272] 10021) (,:[272..273] ,)
        (NNP:[274..277] USA) (.:[277..278] .)))

;sentence 4 Span:282..501
;Recent advances in molecular biological techniques have increased our
;capability  to distinguish the small differences in gene expression between
;subpopulations  of cells found within specific tissues or tumor isolates.
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[282..288] Recent) (NNS:[289..297] advances))
      (PP (IN:[298..300] in)
        (NP (JJ:[301..310] molecular) (JJ:[311..321] biological)
            (NNS:[322..332] techniques))))
    (VP (VBP:[333..337] have)
      (VP (VBN:[338..347] increased)
        (NP (PRP$:[348..351] our) (NN:[352..362] capability)
          (S
            (NP-SBJ (-NONE-:[362..362] *))
            (VP (TO:[364..366] to)
              (VP (VB:[367..378] distinguish)
                (NP
                  (NP (DT:[379..382] the) (JJ:[383..388] small)
                      (NNS:[389..400] differences))
                  (PP (IN:[401..403] in)
                    (NP (NN:[404..408] gene) (NN:[409..419] expression))))
                (PP (IN:[420..427] between)
                  (NP
                    (NP
                      (NP (NNS:[428..442] subpopulations))
                      (PP (IN:[444..446] of)
                        (NP
                          (NP (NNS:[447..452] cells))
                          (VP (VBN:[453..458] found)
                            (NP (-NONE-:[458..458] *))
                            (PP-LOC (IN:[459..465] within)
                              (NP (JJ:[466..474] specific)
                                  (NNS:[475..482] tissues)))))))
                    (CC:[483..485] or)
                    (NP (NN:[486..491] tumor) (NNS:[492..500] isolates))))))))))
    (.:[500..501] .)))

;sentence 5 Span:502..663
;We use subtractive  hybridization or subtractive cloning to generate
;information regarding genes  that direct various aspects of mammalian
;embryonic development.
(SENT
  (S
    (NP-SBJ (PRP:[502..504] We))
    (VP (VBP:[505..508] use)
      (NP
        (NP (JJ:[509..520] subtractive) (NN:[522..535] hybridization))
        (CC:[536..538] or)
        (NP (JJ:[539..550] subtractive) (NN:[551..558] cloning)))
      (S-PRP
        (NP-SBJ (-NONE-:[558..558] *))
        (VP (TO:[559..561] to)
          (VP (VB:[562..570] generate)
            (NP
              (NP (NN:[571..582] information))
              (PP (IN:[583..592] regarding)
                (NP
                  (NP (NNS:[593..598] genes))
                  (SBAR
                    (WHNP-1 (WDT:[600..604] that))
                    (S
                      (NP-SBJ-1 (-NONE-:[604..604] *T*))
                      (VP (VBP:[605..611] direct)
                        (NP
                          (NP (JJ:[612..619] various) (NNS:[620..627] aspects))
                          (PP (IN:[628..630] of)
                            (NP (JJ:[631..640] mammalian)
                                (JJ:[641..650] embryonic)
                                (NN:[651..662] development))))))))))))))
    (.:[662..663] .)))

;sentence 6 Span:664..818
;The technique  also is used to identify genes with specificity for particular
;tissues or cell  types or those that regulate various processes in the cell.
(SENT
  (S
    (NP-SBJ-1 (DT:[664..667] The) (NN:[668..677] technique))
    (ADVP (RB:[679..683] also))
    (VP (VBZ:[684..686] is)
      (VP (VBN:[687..691] used)
        (NP-1 (-NONE-:[691..691] *))
        (S-ADV
          (NP-SBJ (-NONE-:[691..691] *))
          (VP (TO:[692..694] to)
            (VP (VB:[695..703] identify)
              (NP
                (NP (NNS:[704..709] genes))
                (PP (IN:[710..714] with)
                  (NP
                    (NP
                      (NP (NN:[715..726] specificity))
                      (PP (IN:[727..730] for)
                        (NP
                          (NP (JJ:[731..741] particular)
                              (NNS:[742..749] tissues))
                          (CC:[750..752] or)
                          (NP (NN:[753..757] cell) (NNS:[759..764] types)))))
                    (CC:[765..767] or)
                    (NP
                      (NP (DT:[768..773] those))
                      (SBAR
                        (WHNP-2 (WDT:[774..778] that))
                        (S
                          (NP-SBJ-2 (-NONE-:[778..778] *T*))
                          (VP (VBP:[779..787] regulate)
                            (NP (JJ:[788..795] various)
                                (NNS:[796..805] processes))
                            (PP-LOC (IN:[806..808] in)
                              (NP (DT:[809..812] the) (NN:[813..817] cell)))))))))))))))
    (.:[817..818] .)))

;sentence 7 Span:819..908
;Also, subject to  analysis is the aberrant expression of genes involved in
;tumorigenesis.
(SENT
  (SINV
    (ADVP (RB:[819..823] Also))
    (,:[823..824] ,)
    (ADJP-PRD-TPC-1 (JJ:[825..832] subject)
      (PP (TO:[833..835] to)
        (NP (NN:[837..845] analysis))))
    (VP (VBZ:[846..848] is)
      (ADJP-PRD-1 (-NONE-:[848..848] *T*)))
    (NP-SBJ
      (NP (DT:[849..852] the) (JJ:[853..861] aberrant)
          (NN:[862..872] expression))
      (PP (IN:[873..875] of)
        (NP
          (NP (NNS:[876..881] genes))
          (VP (VBN:[882..890] involved)
            (NP (-NONE-:[890..890] *))
            (PP-CLR (IN:[891..893] in)
              (NP (NN:[894..907] tumorigenesis)))))))
    (.:[907..908] .)))

;sentence 8 Span:909..1020
;Another  use is analysis of subpopulations of cell types previously
;identified within  individual solid tumors.
(SENT
  (S
    (NP-SBJ (DT:[909..916] Another) (NN:[918..921] use))
    (VP (VBZ:[922..924] is)
      (NP
        (NP
          (NP (NN:[925..933] analysis))
          (PP (IN:[934..936] of)
            (NP
              (NP (NNS:[937..951] subpopulations))
              (PP (IN:[952..954] of)
                (NP (NN:[955..959] cell) (NNS:[960..965] types))))))
        (VP
          (ADVP-TMP (RB:[966..976] previously))
          (VBN:[977..987] identified)
          (NP (-NONE-:[987..987] *))
          (PP-LOC (IN:[988..994] within)
            (NP (JJ:[996..1006] individual) (JJ:[1007..1012] solid)
                (NNS:[1013..1019] tumors))))))
    (.:[1019..1020] .)))

;sentence 9 Span:1021..1147
;We used subtractive cloning in the analysis of cell  line subpopulations
;derived from the human pediatric tumor neuroblastoma.
;[1117..1126]:malignancy-developmental-state:"pediatric"
;[1133..1146]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (PRP:[1021..1023] We))
    (VP (VBD:[1024..1028] used)
      (NP (JJ:[1029..1040] subtractive) (NN:[1041..1048] cloning))
      (PP (IN:[1049..1051] in)
        (NP
          (NP (DT:[1052..1055] the) (NN:[1056..1064] analysis))
          (PP (IN:[1065..1067] of)
            (NP
              (NP
                (NP (NN:[1068..1072] cell) (NN:[1074..1078] line))
                (NNS:[1079..1093] subpopulations))
              (VP (VBN:[1094..1101] derived)
                (NP (-NONE-:[1101..1101] *))
                (PP-CLR (IN:[1102..1106] from)
                  (NP (DT:[1107..1110] the) (JJ:[1111..1116] human)
                      (JJ:[1117..1126] pediatric) (NN:[1127..1132] tumor)
                      (NN:[1133..1146] neuroblastoma)))))))))
    (.:[1146..1147] .)))

;sentence 10 Span:1148..1253
;This  has resulted in the identification of novel genes that may be useful in
;the  study of this disease.
(SENT
  (S
    (NP-SBJ (DT:[1148..1152] This))
    (VP (VBZ:[1154..1157] has)
      (VP (VBN:[1158..1166] resulted)
        (PP-CLR (IN:[1167..1169] in)
          (NP
            (NP (DT:[1170..1173] the) (NN:[1174..1188] identification))
            (PP (IN:[1189..1191] of)
              (NP
                (NP (JJ:[1192..1197] novel) (NNS:[1198..1203] genes))
                (SBAR
                  (WHNP-1 (WDT:[1204..1208] that))
                  (S
                    (NP-SBJ-1 (-NONE-:[1208..1208] *T*))
                    (VP (MD:[1209..1212] may)
                      (VP (VB:[1213..1215] be)
                        (VP (JJ:[1216..1222] useful)
                          (PP (IN:[1223..1225] in)
                            (NP
                              (NP (DT:[1226..1229] the) (NN:[1231..1236] study))
                              (PP (IN:[1237..1239] of)
                                (NP (DT:[1240..1244] this)
                                    (NN:[1245..1252] disease))))))))))))))))
    (.:[1252..1253] .)))

;section 11 Span:1257..1275
;Publication Types:
(SEC
  (FRAG (NNP:[1257..1268] Publication) (NNP:[1269..1274] Types)
        (::[1274..1275] :)))

;section 12 Span:1281..1287
;Review
(SEC
  (FRAG (NNP:[1281..1287] Review)))

;section 13 Span:1293..1309
;Review, Tutorial
(SEC
  (FRAG (NNP:[1293..1299] Review) (,:[1299..1300] ,) (NNP:[1301..1309] Tutorial)))

;section 14 Span:1313..1357
;PMID: 8858760 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1313..1317] PMID) (::[1317..1318] :) (CD:[1319..1326] 8858760)
        (NN:[1327..1328] -LSB-) (NNP:[1328..1334] PubMed) (::[1335..1336] -)
        (NN:[1337..1344] indexed) (IN:[1345..1348] for)
        (NNP:[1349..1357] MEDLINE-RSB-)))
